"Mandated step therapy for dupilumab delays the inevitable." Journal of Dermatological Treatment, 35(1), pp.
Disclosure statement
Dr. Flowers serves as a principal investigator for Abbvie, Acelyrin, Regeneron/Sanofi and Sun Pharmaceuticals. He has served on advisory boards for Argenx, Bristol-Myers Squibb and Janssen.